heat News and Research

RSS

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects.

23 Feb 2010

Nutrient-rich California avocados hit grocery stores

California avocado season has arrived, making this delectable fruit readily available at grocery stores throughout the country. March through September marks the California avocado season, so now is the perfect time to incorporate this premium fruit in avocado-centric recipes created by chefs Mary Sue Milliken and Susan Feniger.

19 Feb 2010

Universal Detection Technology to commence marketing of passive zone security sensor

Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sensor, developed through its partnership with Precision Sensors Instrumentation (PSI), a leading developer of security sensors.

19 Feb 2010

MetLife Mature Market Institute provides history of generations born since early 1900s

A series of publications from the MetLife Mature Market Institute provide a history of the generations born since the early 1900s. There are almost as many members of Gen Y (born 1977-1994) in the U.S. in comparison to the largest group, the Baby Boomers.

19 Feb 2010

Detroit home health agency owner pleads guilty over Medicare fraud

Detroit-area resident Muhammad Shahab pleaded guilty today for his role in organizing a Detroit-area home health care fraud scheme, announced Assistant Attorney General Lanny Breuer of the Criminal Division; U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office; and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services, Office of Inspector General's (HHS-OIG), Chicago Regional Office.

18 Feb 2010

Healthy immune response depends on TRPV2 protein

If bad bacteria lurk in your system, chances are they will bump into the immune system's protective cells whose job is gobbling germs.

18 Feb 2010

WellPoint cancels investor meeting to prepare for congressional hearing on premium hikes

WellPoint, the parent company of Anthem Blue Cross, has canceled an investor meeting "so that executives can prepare for a congressional hearing on the company's large rate hikes in California," the Los Angeles Times reports. "A subcommittee of the House Committee on Energy and Commerce has called WellPoint Inc. Chief Executive Angela F. Braly to testify Feb. 24 about planned premium increases of as much as 39% for many of Anthem's 800,000 individual policyholders in California."

17 Feb 2010

Fourth-quarter and full-year 2009 results announced by Celsion

Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.

17 Feb 2010

APS-AAPT joint meeting: Highlights

Secret military projects, powerful collisions at the LHC, future international physics projects, and lots of new data from around the universe will be featured in talks at this year's spring meeting of The American Physical Society (APS), the largest professional society of physicists in the world. This year, APS is joining with the American Association of Physics Teachers (AAPT), the world's largest society of physics teachers, for a joint meeting from February 13-17, 2010 at the Marriott Wardman Park Hotel in Washington, D.C.

15 Feb 2010

GM crops can help bolster global food security, scientists say in special journal issue

Acceptance of genetically modified (GM) crops in agriculture will help bolster global food security as the world faces population growth and the potential effects of climate change, Nina Fedoroff, science and technology advisor to Secretary of State Hillary Rodham Clinton, and colleagues write in an article published in a special issue of the journal Science, the Times of London reports.

15 Feb 2010

Debiopharm receives AFSSAPS approval of CTA for Debio 0932 inhibitor, triggers milestone payment to Curis

Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis’ and Debiopharm’s August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.

12 Feb 2010

First Edition: February 12, 2010

Today's headlines highlight the continuing flap over Anthem Blue Cross' planned rate hike as well as GOP and Democratic responses to President Obama's proposed health summit.

12 Feb 2010

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise metabolism, and/or scientific policies related to sports nutrition.

12 Feb 2010

FDA grants approval for Abbott's antiretroviral medication Norvir

Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir ® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients.

11 Feb 2010

Oral hygiene: Insights

Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.

11 Feb 2010

Barley beta-glucan soluble fiber lowers cholesterol and reduces risk for coronary heart disease

According to statistics from the Centers for Disease Control and Prevention, heart disease continues to be the leading cause of death in the United States and is also a major cause of disability. But the good news is improving heart health can be as easy as making simple lifestyle changes like choosing foods with proven heart health-promoting attributes.

11 Feb 2010

Congress to investigate 39 percent premium hike by California's Anthem Blue Cross

San Francisco Chronicle: "Angry lawmakers turned up the heat on Anthem Blue Cross on Tuesday, calling for federal and state investigations into the California health insurer's decision to increase rates by as much as 39 percent for thousands of policyholders statewide."

10 Feb 2010

DMC recommends Celsion to continue its Phase III ThermoDox clinical trial for primary liver cancer

Celsion Corporation announced today that after reviewing safety data from 120 patients enrolled in the pivotal Phase III ThermoDox® clinical trial ("HEAT" trial) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.

10 Feb 2010

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Luth Research's IndicatorEDG survey finds Americans are less likely to feel their dreams are attainable. Back in the third quarter of 2006, 62% of Americans said they had an excellent, very good or good chance of achieving their personal dreams.

10 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

heat News and Research

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

Nutrient-rich California avocados hit grocery stores

Universal Detection Technology to commence marketing of passive zone security sensor

MetLife Mature Market Institute provides history of generations born since early 1900s

Detroit home health agency owner pleads guilty over Medicare fraud

Healthy immune response depends on TRPV2 protein

WellPoint cancels investor meeting to prepare for congressional hearing on premium hikes

Fourth-quarter and full-year 2009 results announced by Celsion

APS-AAPT joint meeting: Highlights

GM crops can help bolster global food security, scientists say in special journal issue

Debiopharm receives AFSSAPS approval of CTA for Debio 0932 inhibitor, triggers milestone payment to Curis

First Edition: February 12, 2010

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

FDA grants approval for Abbott's antiretroviral medication Norvir

Oral hygiene: Insights

Barley beta-glucan soluble fiber lowers cholesterol and reduces risk for coronary heart disease

Congress to investigate 39 percent premium hike by California's Anthem Blue Cross

DMC recommends Celsion to continue its Phase III ThermoDox clinical trial for primary liver cancer

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News